CommercialPrior AuthMedium impact
Hematopoietic Cell Transplantation in the Treatment of Germ Cell Tumors
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Hematology, Urology·Medical Policy
We identified it
Jun 20, 2026
Summary
Blue Cross & Blue Shield of Mississippi updated their policy for hematopoietic cell transplantation in treating germ cell tumors, establishing specific medical necessity criteria for autologous transplants and requiring prior authorization through case management for all transplant procedures and evaluations.
Action Required
Immediately: Billing team must ensure prior authorization is obtained through Blue Cross & Blue Shield of Mississippi case management before scheduling any hematopoietic cell transplant procedures or evaluations for germ cell tumor patients. Update pre-authorization checklist to include this requirement. Claims will be denied without prior authorization.